Detalhe da pesquisa
1.
A Non-D2-Receptor-Binding Drug for the Treatment of Schizophrenia.
N Engl J Med
; 382(16): 1497-1506, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32294346
2.
Efficacy and safety of dasotraline in adults with binge-eating disorder: a randomized, placebo-controlled, fixed-dose clinical trial.
CNS Spectr
; 26(5): 481-490, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32423512
3.
The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman's disease.
Brain Behav Immun
; 66: 156-164, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28676350
4.
Risk of cardiovascular morbidity with risperidone or paliperidone treatment: analysis of 64 randomized, double-blind trials.
J Clin Psychopharmacol
; 33(2): 157-61, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23422378
5.
Metabolic and body mass parameters after treatment with JNJ-37822681, a novel fast-dissociating D2 receptor antagonist, vs olanzapine in patients with schizophrenia.
Ann Clin Psychiatry
; 25(3): 173-83, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23926573
6.
Doubly randomized delayed-start design for enrichment studies with responders or nonresponders.
J Biopharm Stat
; 22(4): 737-57, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22651112
7.
A Randomized, Double-blind, Placebo-controlled Proof-of-Concept Trial to Evaluate the Efficacy and Safety of Non-racemic Amisulpride (SEP-4199) for the Treatment of Bipolar I Depression.
J Affect Disord
; 296: 549-558, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34614447
8.
The incidence and economic burden of extrapyramidal symptoms in patients with schizophrenia treated with second generation antipsychotics in a Medicaid population.
J Med Econ
; 25(1): 87-98, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34913797
9.
Burden of EPS in commercial patients with schizophrenia initiating atypical antipsychotics.
Am J Manag Care
; 28(9): e315-e324, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36121363
10.
Dasotraline in adults with attention deficit hyperactivity disorder: a placebo-controlled, fixed-dose trial.
Int Clin Psychopharmacol
; 36(3): 117-125, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724251
11.
Efficacy and Safety of Dasotraline in Children With ADHD: A Laboratory Classroom Study.
J Atten Disord
; 24(2): 192-204, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31375051
12.
Neural circuitry of submissive behavior in social anxiety disorder: A preliminary study of response to direct eye gaze.
Psychiatry Res
; 173(3): 248-50, 2009 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19628377
13.
Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.
Transl Psychiatry
; 9(1): 240, 2019 Oct 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31578318
14.
The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder.
Transl Psychiatry
; 9(1): 216, 2019 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31481683
15.
Dasotraline in Children with Attention-Deficit/Hyperactivity Disorder: A Six-Week, Placebo-Controlled, Fixed-Dose Trial.
J Child Adolesc Psychopharmacol
; 29(2): 80-89, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30694697
16.
The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia.
J Psychopharmacol
; 33(2): 202-209, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30644312
17.
A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity.
J Psychopharmacol
; 32(6): 668-677, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29848147
18.
Longitudinal Predictive Validity of the DSM-5 Anxious Distress Specifier for Clinical Outcomes in a Large Cohort of Patients With Major Depressive Disorder.
J Clin Psychiatry
; 78(2): 207-213, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27035515
19.
Anxious distress predicts subsequent treatment outcome and side effects in depressed patients starting antidepressant treatment.
J Psychiatr Res
; 84: 41-48, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27693981
20.
Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography.
Biol Psychiatry
; 59(9): 821-8, 2006 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16213473